Free Trial

Corbus Pharmaceuticals (CRBP) Insider Trading & Ownership

Corbus Pharmaceuticals logo
$13.07 -0.10 (-0.76%)
(As of 12:22 PM ET)

Corbus Pharmaceuticals (NASDAQ:CRBP) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
4.00%
Number Of
Insiders Buying
(Last 12 Months)
4
Amount Of
Insider Buying
(Last 12 Months)
$40.38 M
Number Of
Insiders Selling
(Last 12 Months)
2
Amount Of
Insider Selling
(Last 12 Months)
$2.53 M
Get CRBP Insider Trade Alerts

Want to know when executives and insiders are buying or selling Corbus Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

CRBP Insider Buying and Selling by Quarter

Corbus Pharmaceuticals Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/20/2024Cormorant Asset Management, LpMajor ShareholderBuy350,000$20.01$7,003,500.00  
6/18/2024Sean F MoranCFOSell1,958$42.12$82,470.96  
6/17/2024Yuval CohenCEOSell11,103$46.02$510,960.06  
6/14/2024Sean F MoranCFOSell9,355$49.87$466,533.85  
6/14/2024Yuval CohenCEOSell29,317$50.17$1,470,833.89  
3/7/2024Cormorant Asset Management, LpMajor ShareholderBuy250,000$40.05$10,012,500.00  
2/2/2024Cormorant Asset Management, LpMajor ShareholderBuy750,000$19.00$14,250,000.00  
1/26/2024Cormorant Asset Management, LpMajor ShareholderBuy282,632$32.24$9,112,055.68  
(Data available from 1/1/2013 forward)

CRBP Insider Trading Activity - Frequently Asked Questions

The list of insiders at Corbus Pharmaceuticals includes Cormorant Asset Management, Lp, Craig Stuart Millian, Sean F Moran, and Yuval Cohen. Learn more on insiders at CRBP.

4.00% of Corbus Pharmaceuticals stock is owned by insiders. Learn more on CRBP's insider holdings.

The following insider purchased CRBP shares in the last 24 months: Cormorant Asset Management, Lp ($40,378,055.68).

Insiders have purchased a total of 1,632,632 CRBP shares in the last 24 months for a total of $40,378,055.68 bought.

The following insiders have sold CRBP shares in the last 24 months: Sean F Moran ($549,004.81), and Yuval Cohen ($1,981,793.95).

Insiders have sold a total of 51,733 Corbus Pharmaceuticals shares in the last 24 months for a total of $2,530,798.76 sold.

Corbus Pharmaceuticals Key Executives

  • Dr. Yuval Cohen Ph.D. (Age 49)
    CEO & Director
    Compensation: $907.78k
  • Mr. Sean F. Moran CPA (Age 66)
    M.B.A., Chief Financial Officer
    Compensation: $609.28k
  • Ms. Lindsey Smith
    Head of Corporate Communications & Patient Advocacy
  • Ms. Christina Bertsch
    Head of Human Resources
  • Dr. Dominic Smethurst M.A. (Age 49)
    M.D., Chief Medical Officer


This page (NASDAQ:CRBP) was last updated on 12/26/2024 by MarketBeat.com Staff
From Our Partners